Table 1.

Characterization of drug-loaded nanoparticles

Polymer	Drug loading (%)	Surfactant	Size (nm)	PDI	ZP (mV)	EE (%)
PLGA-TPGS	2.5	No	207.15 ± 8. 46	0.321 ± 0.03		58.87 ± 3.25
PLGA-TPGS	5	No	223.92 ± 6.27	0.372 ± 0.04		52.58 ± 2.94
PLGA-TPGS	10	No	244.71 ± 6.65	0.415 ± 0.02	−24.09 ± 1.45	48.35 ± 5.73
PLGA-TPGS	10	0.03% TPGS	265.43 ± 6.52	0.364 ± 0.03	−18.03 ± 1.89	99.31 ± 0.56
PLGA-TPGS	10	0.06% TPGS	290.25 ± 7.64	0.485 ± 0.01	−15.22 ± 2.12	85.85 ± 3.14
PLGA	10	0.03% TPGS	233.83 ± 9.62	0.293 ± 0.03	−32.10 ± 0.65	75.63 ± 3.42

* PDI Polydispersity Index, EE Drug encapsulation efficiency, n = 3